Bo Rode Hansen

individual

Ecosystem influencer

About

Bo Rode Hansen is a biotech executive and board leader with more than two decades of experience across R&D, business development, financing, IPOs, and M&A. He is currently CEO ad interim at LIfT BioSciences and Chairman of TECregen, and previously served as CEO and President of Scandion Oncology. Earlier roles include founding President of Genevant Sciences and senior leadership positions at Roche and Santaris Pharma.

Areas of interest

biotechoncologyimmunologycell therapyRNA therapeuticsrare diseasesthymus regenerationdrug developmentventure-backed life sciences